{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:05:40Z","timestamp":1758773140641,"version":"3.44.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["21K15818"],"award-info":[{"award-number":["21K15818"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,23]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Lymphopenia during chemoradiotherapy (CRT) for glioblastoma has been shown to be a poor prognostic factor. However, the relationship between prolonged lymphopenia (PL) after CRT and prognosis remains unclear. This study aimed to explore the relationship between PL and glioblastoma prognosis and develop a predictive model for PL risk. We analyzed 87 patients with primary glioblastoma who underwent postoperative CRT with 60\u00a0Gy in 30 fractions of radiotherapy and temozolomide. PL was defined as grade 2 or higher lymphopenia 1 month after the completion of CRT. We conducted survival analysis, identified risk factors for PL, and developed a predictive model for PL risk. Of the 87 patients, 41 developed PL, and progression-free survival (PFS) was significantly shorter in the PL group (median 8.0\u00a0months vs 15.4\u00a0months, P\u2009=\u20090.003). However, there was no significant difference in overall survival between the two groups. PL was also a significant factor for shorter PFS in multivariable analysis (P\u2009=\u20090.040). Brain V20Gy (percentage of brain volume receiving \u226520\u00a0Gy), gross total resection (GTR), and preoperative Karnofsky performance status (KPS) were identified as significant risk factors for PL. The predictive model showed that the risk of PL could be predicted by brain V20Gy, sex, age, GTR and preoperative KPS. PL was identified as a PFS shortening factor. Our model suggests that reducing irradiated brain volume may help prevent PL and could potentially improve glioblastoma prognosis by preserving cancer immunity.<\/jats:p>","DOI":"10.1093\/jrr\/rraf045","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:45:01Z","timestamp":1755038701000},"page":"542-550","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of prognostic value and development of predictive model for prolonged lymphopenia in patients with glioblastoma following chemoradiotherapy"],"prefix":"10.1093","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4742-4325","authenticated-orcid":false,"given":"Shuhei","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Graduate School of Medicine, Hokkaido University , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638 ,","place":["Japan"]},{"name":"Department of Radiation Oncology, Hokkaido University Hospital , Kita 14, Nishi 6, Kita-ku, Sapporo 060-8648 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8272-7603","authenticated-orcid":false,"given":"Kentaro","family":"Nishioka","sequence":"additional","affiliation":[{"name":"Global Center for Biomedical Science and Engineering, Hokkaido University , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5246-215X","authenticated-orcid":false,"given":"Takashi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Hokkaido University Hospital , Kita 14, Nishi 6, Kita-ku, Sapporo 060-8648 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, Hokkaido University , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitomo","family":"Ishi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, Hokkaido University , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-8128","authenticated-orcid":false,"given":"Keiji","family":"Kobashi","sequence":"additional","affiliation":[{"name":"Global Center for Biomedical Science and Engineering, Hokkaido University , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5073-0827","authenticated-orcid":false,"given":"Yoichi M","family":"Ito","sequence":"additional","affiliation":[{"name":"Data Science Center, Promotion Unit, Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital , Kita 14, Nishi 6, Kita-ku, Sapporo 060-8648 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zen-ichi","family":"Tanei","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology, Faculty of Medicine, Hokkaido University , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kanno-Okada","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital , Kita 14, Nishi 6, Kita-ku, Sapporo 060-8648 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-3301","authenticated-orcid":false,"given":"Shinya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology, Faculty of Medicine, Hokkaido University , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638 ,","place":["Japan"]},{"name":"Department of Surgical Pathology, Hokkaido University Hospital , Kita 14, Nishi 6, Kita-ku, Sapporo 060-8648 ,","place":["Japan"]},{"name":"Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University , Kita 21, Nishi 10, Kita-ku, Sapporo 001-0021 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Aoyama","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Graduate School of Medicine, Hokkaido University , Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638 ,","place":["Japan"]},{"name":"Department of Radiation Oncology, Hokkaido University Hospital , Kita 14, Nishi 6, Kita-ku, Sapporo 060-8648 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"2025092423163164000_ref1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Investig"},{"key":"2025092423163164000_ref2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"2025092423163164000_ref3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ijrobp.2015.04.005","article-title":"Clinical and dosimetric predictors of acute severe lymphopenia during radiation therapy and concurrent temozolomide for high-grade glioma","volume":"92","author":"Huang","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025092423163164000_ref4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","article-title":"Effect of radiation treatment volume reduction on lymphopenia in patients receiving chemoradiotherapy for glioblastoma","volume":"101","author":"Rudra","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025092423163164000_ref5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/neuonc\/noaa182","article-title":"Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons","volume":"23","author":"Mohan","year":"2021","journal-title":"Neuro-Oncology"},{"key":"2025092423163164000_ref6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.radonc.2021.06.020","article-title":"Impact of effective dose to immune cells (EDIC) on lymphocyte nadir and survival in limited-stage SCLC","volume":"162","author":"Yu","year":"2021","journal-title":"Radiother Oncol"},{"key":"2025092423163164000_ref7","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1111\/1759-7714.13621","article-title":"Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer","volume":"11","author":"Matiello","year":"2020","journal-title":"Thorac Cancer"},{"key":"2025092423163164000_ref8","doi-asserted-by":"publisher","first-page":"E1061","DOI":"10.1002\/hed.24158","article-title":"Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer","volume":"38","author":"Cho","year":"2016","journal-title":"Head Neck"},{"key":"2025092423163164000_ref9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11060-019-03167-2","article-title":"Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma","volume":"143","author":"Kim","year":"2019","journal-title":"J Neuro-Oncol"},{"key":"2025092423163164000_ref10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13014-019-1256-6","article-title":"Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era","volume":"14","author":"Byun","year":"2019","journal-title":"Radiat Oncol"},{"key":"2025092423163164000_ref11","first-page":"1","article-title":"Impact of lymphopenia on survival for elderly patients with glioblastoma: a secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG08.02) randomized clinical trial","volume":"3","author":"Song","year":"2021","journal-title":"Neurooncol Adv"},{"key":"2025092423163164000_ref12","doi-asserted-by":"publisher","first-page":"100799","DOI":"10.1016\/j.ctro.2024.100799","article-title":"Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy based-chemoradiation therapy for newly diagnosed glioblastoma: a multi-institutional study","volume":"47","author":"Kim","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"2025092423163164000_ref13","first-page":"69","article-title":"Early and late effects of irradiation for seminoma testis on the number of blood lymphocytes and their B and T subpopulations","volume":"8","author":"Heier","year":"1975","journal-title":"Lymphology"},{"key":"2025092423163164000_ref14","doi-asserted-by":"publisher","first-page":"eabn6758","DOI":"10.1126\/scitranslmed.abn6758","article-title":"Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma","volume":"15","author":"Ghosh","year":"2023","journal-title":"Sci Transl Med"},{"key":"2025092423163164000_ref15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.radonc.2020.07.026","article-title":"Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer","volume":"151","author":"Lee","year":"2020","journal-title":"Radiother Oncol"},{"key":"2025092423163164000_ref16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13014-023-02354-w","article-title":"Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs","volume":"18","author":"Tseng","year":"2023","journal-title":"Radiat Oncol"},{"key":"2025092423163164000_ref17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3349\/ymj.2022.0352","article-title":"Clinical outcomes of moderately hypofractionated concurrent chemoradiotherapy for newly diagnosed glioblastoma","volume":"64","author":"Kim","year":"2023","journal-title":"Yonsei Med J"},{"key":"2025092423163164000_ref18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/neup.12091","article-title":"Immunohistochemical evaluation of O6-methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma","volume":"34","author":"Miyazaki","year":"2014","journal-title":"Neuropathology."},{"key":"2025092423163164000_ref19","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059","article-title":"RANO 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults","volume":"41","author":"Wen","year":"2023","journal-title":"J Clin Oncol"},{"key":"2025092423163164000_ref20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.surge.2010.07.011","article-title":"Surgery induced immunosuppression","volume":"9","author":"Hogan","year":"2011","journal-title":"Surgeon"},{"key":"2025092423163164000_ref21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/neuonc\/noac099","article-title":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial","volume":"25","author":"Omuro","year":"2023","journal-title":"Neuro-Oncology"},{"key":"2025092423163164000_ref22","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro-Oncology"},{"key":"2025092423163164000_ref23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat Med"},{"key":"2025092423163164000_ref24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/jrr\/rry106","article-title":"Selection criteria for 3D conformal radiotherapy versus volumetric-modulated arc therapy in high-grade glioma based on normal tissue complication probability of brain","volume":"60","author":"Tanabe","year":"2019","journal-title":"J Radiat Res"},{"key":"2025092423163164000_ref25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.7785\/tcrt.2012.500341","article-title":"IMRT or 3D-CRT in glioblastoma? A dosimetric criterion for patient selection","volume":"12","author":"Lorentini","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"2025092423163164000_ref26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4236\/jct.2013.411A003","article-title":"Dosimetric improvements utilising intensity modulated radiation therapy for patients with glioblastoma multiforme","volume":"04","author":"Back","year":"2013","journal-title":"J Cancer Ther"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/66\/5\/542\/63999259\/rraf045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/66\/5\/542\/63999259\/rraf045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:16:56Z","timestamp":1758770216000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/66\/5\/542\/8230130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,8,11]]},"published-print":{"date-parts":[[2025,9,23]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rraf045","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"type":"print","value":"0449-3060"},{"type":"electronic","value":"1349-9157"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,11]]}}}